To the Editor:
Haraoui, et al1 have responded positively to the challenge of improving the care of patients with rheumatoid arthritis (RA), indicating that it is time to “specifically target remission/low disease activity state,” “use consistent measures and metrics,” “respond appropriately” to inadequate therapeutic response, and “optimize therapy.” These suggested actions are in response to data collected in the national audit, Assessments in Rheumatology (AIR) program, which identified, with a cross-sectional survey, that patients with RA do not always receive optimal medicinal therapy despite being in a state of smoldering or active disease.
The authors suggest a “national …
Address correspondence to Dr. Edworthy; E-mail: sedworth{at}ucalgary.ca